A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
Clinical trial NCT00973141 · TERMINATED
Trial details
- NCT number
- NCT00973141
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-16
- Primary completion
- 2011-06-30
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.